
Adapalene
Adapalene is a naphthoic acid that is CD437 in which the phenolic hydroxy group has been converted to its methyl ether. It has a role as a non-steroidal anti-inflammatory drug, a dermatologic drug and an EC 2.7.11.22 (cyclin-dependent kinase) inhibitor. It is a monocarboxylic acid, a naphthoic acid and a member of adamantanes. It is functionally related to a CD437. — ChEBI
- IUPAC-Name
- 6-[3-(1-adamantyl)-4-methoxyphenyl]naphthalene-2-carboxylic acid
- Summenformel
- C28H28O3
- Molekulargewicht
- 412.5 g/mol
- Exakte Masse
- 412.20384475 Da
- XLogP3
- 7,7
- Topologische polare Oberfläche
- 46,5 Ų
- Wasserstoffbrücken-Donoren
- 1
- Wasserstoffbrücken-Akzeptoren
- 3
- Kovalente Einheiten
- 1
- Definierte Stereozentren
- 0
Auch bekannt als
16 weitere gemeldete Namen
Kennungen in externen Datenbanken
- ChEBI:CHEBI:31174
- ChEMBL:CHEMBL1265
- ChEMBL:CHEMBL4303650
- EPA DTXSID:DTXSID5046481
- PubMed:24177211
- PubMed:22988653
- PubMed:22908733
- PubMed:22859236
- PubMed:22847319
- PubMed:22808305
- PubMed:22779096
- PubMed:22772617
- PubMed:22728381
- PubMed:22677304
- PubMed:22648218
- PubMed:22615511
Belege aus weiteren wissenschaftlichen Datenbanken
EMBL-EBI ChEBI
adapalene
A naphthoic acid that is CD437 in which the phenolic hydroxy group has been converted to its methyl ether.
- Rezeptur
- C28H28O3
- Durchschnittsmasse
- 412.529 g/mol
- Monoisotopische Masse
- 412.20384 Da
- Formale Ladung
- 0
- naphthoic acid — is a (CHEBI:25483)
- monocarboxylic acid — is a (CHEBI:25384)
- adamantanes — is a (CHEBI:51339)
- dermatologic drug — has role (CHEBI:50177)
- non-steroidal anti-inflammatory drug — has role (CHEBI:35475)
- EC 2.7.11.22 (cyclin-dependent kinase) inhibitor — has role (CHEBI:82665)
- CD437 — has functional parent (CHEBI:88334)
- dermatologic drug — has role (CHEBI:50177)
- non-steroidal anti-inflammatory drug — has role (CHEBI:35475)
- EC 2.7.11.22 (cyclin-dependent kinase) inhibitor — has role (CHEBI:82665)
- naphthoic acid — is a (CHEBI:25483)
- monocarboxylic acid — is a (CHEBI:25384)
- adamantanes — is a (CHEBI:51339)
- 11594670 Quelle: PubMed
- 12833014 Quelle: PubMed
- 16472241 Quelle: PubMed
- 18759424 Quelle: PubMed
- 22194678 Quelle: PubMed
- 23956101 Quelle: PubMed
- 25016424 Quelle: PubMed
- 25790278 Quelle: PubMed
- 26398439 Quelle: PubMed
- 26483036 Quelle: PubMed
- 29706423 Quelle: PubMed
- 30852084 Quelle: PubMed
- 34812616 Quelle: PubMed
- 35820623 Quelle: PubMed
- 37468498 Quelle: PubMed
- 8544175 Quelle: PubMed
Weitere kuratierte Namen
Querverweise aus dieser Quelle
Zugeordnet durch: Exact CAS cross-reference in the ChEBI compound record. Quelle aktualisiert: 2017-02-22. Abgerufen: 2026-08-31. Quelleneintrag öffnen
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Boiling Point: 606.3 Quelle: DrugBank
- LogP: 6.917 Quelle: DrugBank
- LogP: 8.6 Quelle: Human Metabolome Database (HMDB)
- Melting Point: 300 Quelle: DrugBank
- Physical Description: Solid Quelle: Human Metabolome Database (HMDB)
- Solubility: 4.01e-06 g/L Quelle: Human Metabolome Database (HMDB)
- Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). Quelle: Toxin and Toxin Target Database (T3DB)
- Exposure Routes: Absorption of adapalene through human skin is low. Only trace amounts (<0.25 ng/mL) of parent substance have been found in the plasma of acne patients following chronic topical application of adapalene in controlled clinical trials Quelle: Toxin and Toxin Target Database (T3DB)
- Note: This chemical does not meet GHS hazard criteria for 9.1% (1 of 11) of reports. Quelle: European Chemicals Agency (ECHA)
- Signal: Warning Quelle: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H302 (18.2%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (72.7%): Causes skin irritation [Warning Skin corrosion/irritation]; H317 (54.5%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (72.7%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (18.2%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]; H361 (81.8%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity] Quelle: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P203, P261, P264, P264+P265, P270, P271, P272, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P330, P332+P317, P333+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement) Quelle: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 11 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 1 of 11 reports by companies.; There are 6 notifications provided by 10 of 11 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Quelle: European Chemicals Agency (ECHA)
- Health Effects: Chronic ingestion of the drug may lead to the same side effects as those associated with excessive oral intake of Vitamin A. Quelle: Toxin and Toxin Target Database (T3DB)
- Toxicity Summary: If the adapalene is applied excessively, marked redness, scaling, or skin discomfort may occur. In addition, according to product labeling, chronic ingestion of the drug may lead to the same adverse drug reactions associated with excessive oral intake of vitamin A. Quelle: StatPearls
- Toxicity Summary: Mechanistically, adapalene binds to specific retinoic acid nuclear receptors (gamma and beta) and retinoid X receptors but does not bind to the cytosolic receptor protein. Although the exact mode of action of adapalene is unknown, it is suggested that topical adapalene may normalize the differentiation of follicular epithelial cells resulting in decreased microcomedone formation. Quelle: Toxin and Toxin Target Database (T3DB)
- Uses: Use (kg) in USA (2002): 78; Consumption (g per capita) in the USA (2002): 0.000278; Calculated removal (%): 97.7 Quelle: NORMAN Suspect List Exchange
- Uses: For the topical treatment of comedo, papular and pustular acne (acne vulgaris) of the face, chest or back. Quelle: Toxin and Toxin Target Database (T3DB)
Zugeordnet durch: Existing checksum-valid CAS to unique PubChem CID match. Abgerufen: 2026-08-31. Quelleneintrag öffnen
Wissenschaftliche Klassifizierungen und Gefahrenannotationen liefern Kontext und ersetzen nicht die oben gezeigte marktspezifische regulatorische Entscheidung.
Weitere Quellenabdeckung und Trefferstatus
| Quelle | Ergebnis | Geprüft |
|---|---|---|
| EMBL-EBI ChEBI | Exakter Treffer | 2026-08-31 |
| NIH PubChem PUG-View | Exakter Treffer | 2026-08-31 |
Ein erfasster Nicht-Treffer ist ein nützlicher Beleg dafür, dass die Quelle geprüft wurde; er ist keine Behauptung, dass der Stoff anderswo nicht existiert.
Am 2026-08-31 von NIH PubChem durch prüfsummengültigen CAS-Abgleich abgerufen. Chemische Eigenschaften ersetzen nicht die regulatorische Entscheidung auf dieser Seite.